Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
BLLN · against 229 other Healthcare companies of similar size
Ranked #22 of 230 · scores higher than 90% of peers
Bars: peers in each 10-point band of the profitability score24 peers with a profitability score of 90–100, including BLLN · Click a bar to see the companies
Mainly thanks to its return on invested capital, return on assets and operating margin, which are stronger than most Healthcare peers.
| Metric | BLLN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 222 reported | 43.2% | 8.1% | 95% | 33% | |
| Operating marginHigher is better · 209 reported | 10.9% | 10.9% | 50% | 33% | |
| Return on assetsHigher is better · 220 reported | 5.2% | 2.8% | 67% | 33% | |
| Return on equityHigher is better · 215 reported | 10.7% | 7.5% | 64% | Context only | |
| Gross marginHigher is better · 238 reported | 71.3% | 49.6% | 79% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 3 | 51.3B ZAR (≈$2.8B) | 99 | 73 | |
| 3 | 3.8B USD | 99 | 71 | |
| 3 | 2.7B USD | 99 | 84 | |
| 18 | 249.2B INR (≈$3.0B) | 93 | 73 | |
| 20 | 26.9B CNY (≈$3.8B) | 92 | 65 | |
| 20 | 5.2B CHF (≈$5.9B) | 92 | 69 | |
| 22 | 22.7B CNY (≈$3.2B) | 91 | 75 | |
| 22 | 5.2B USD | 91 | 74 | |
| 22 | 679.6B INR (≈$8.2B) | 91 | 77 | |
| 25 | 27.6B SEK (≈$2.8B) | 88 | 76 | |
| 25 | 6.6B USD | 88 | 61 | |
| 27 | 10.8B SAR (≈$2.9B) | 87 | 68 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score